期刊文献+

蛛网膜下腔再出血原因分析及预防 被引量:1

CAUSES ANALYSIS AND PREVENTION OF REBLEEDING IN SUBARACHNOID HEMORRHAGE
下载PDF
导出
摘要 [目的]探讨蛛网膜下腔出血(SAH)再出血的危险因素及诱发因素。[方法]78例蛛网膜下腔出血患者住院治疗并随访观察6个月,对31例再出血的SAH患者(病例组)与无再出血的47例SAH患者(对照组)的有关危险因素进行比较。[结果]78例SAH的再出血率是39.7%;再出血组发病年龄﹥60岁,Hunt-Hess分级Ⅲ级及以上、伴高血压、动脉瘤、入院时间﹥24 h的比率均高于对照组。[结论]发病年龄﹥60岁、Hunt-Hess分级Ⅲ级及以上、伴高血压、动脉瘤、入院时间﹥24 h是SAH患者再出血的危险因素。预防再出血需注意控制危险因素,避免诱发因素。 [ Objective] To explore the risk factors and causative factors of rebleeding in subarachnoid hemorrhage. [ Methods ] 78 patients who survived the subarachnoid hemorrhage were followed up for 6 months after the bleeding. The risk factors were compared between the two groups of 31 cases with rebleeding (rebleeding group), and 47 cases without rebleeding (control group). [ Results] The rebleeding rate of the 78 patients was 39.7%. The percentage of which patients had the risk factors of being over 60, grade Ⅲ and above of Hunt-Hess grade, hypertension, aneurysm, admission over 24 hours after the first attack in the rebleeding group was higher than that in the control group. [Conclusion] Being over 60 years old, grade Ⅲ and above of Hunt-Hess grade, hypertension, aneurysm, admission over 24 hours after the first attack are the risk factors of rebleeding in subarachnoid hemorrhage. The prevention of rebleeding is to control the risk factors and avoid the causative factors.
出处 《现代预防医学》 CAS 北大核心 2007年第15期2981-2982,共2页 Modern Preventive Medicine
关键词 蛛网膜下腔再出血 原因 预防 Rebleeding in subarachnoid hemorrhage Causes Prevention
  • 相关文献

参考文献4

二级参考文献19

  • 1Chyatte D, Lewis I. Gelatinaseactivity and the occurrence of cerebral aneurysms. Stroke, 1997, 28(4): 799-804.
  • 2Stehbens WE. Etiology of intracranial berry aneurysms. J Neurosurg, 1989, 70(6):823-831.
  • 3Stehbens WE. Pathology and pathogenesis of intracranial berry aneurysms. NeurolRes, 1990, 12(1 ): 29-34.
  • 4Gao YZ, van Alphen HA. Pathogenesis and histopathology of saccular aneurysms:review of the literature. Neurol Res, 1990, 12(4):249-255.
  • 5Kim SC, Singh M, Huang J, et al. Matrix metalloproteinase-9 in cere bral aneurysms.Neurosurgery, 1997, 41 (3): 642-647.
  • 6Todor DR, Lewis I, Bruno G, et al. Identification of a serum gelatinase associatedwith the occurrence of cerebralaneurysms as promatrix metalloproteinase-2. Stroke, 1998,29(8): 1580-1583.
  • 7Bruno G, Todor R, Lewis I, et al. Vascular extracellular matrix remodeling incerebral aneurysms. J Neurosurg, 1998, 89(3): 431-440.
  • 8Peters DG, Kassam A, St Jean PL, et al. Functional polymorphism in the matrixmetalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke,1999, 30(12): 2612-2616.
  • 9Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical studies ofatherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol, 1994,53(4): 399-406.
  • 10Chyatte D, Bruno G, Desai S, et al. Inflammation and intracranial aneurysms.Neurosurgery, 1999, 45(5): 1137-1147.

共引文献9

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部